Opinion/decision on a Paediatric investigation plan (PIP): Takhzyro, lanadelumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Other, PIP number: P/0037/2023
Submitted by Anonymous (not verified) on 14 February 2024 - 13:34
Opinion/decision on a Paediatric investigation plan (PIP): Takhzyro, lanadelumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Other, PIP number: P/0037/2023